Powered by Roche & aMoon
Menu
StarFinder Lab invests in the most promising entrepreneurs and teams that develop highly innovative AI-BASED solutions for some of the most pressing global health challenges.
Powered by Roche and aMoon, we provide ACCESS and TOOLS through a uniquely tailored 9-month program.
StarFinder is an exclusive innovation program for entrepreneurs to execute ‘Proof of Concept’ (POC) AI-based projects in order to address global Healthcare market needs.
Established in 2020 by Roche and aMoon Fund, this unique early stage investment program is aimed at identifying exceptional entrepreneurs who are addressing pressing global health challenges.
The collaboration, called “StarFinder Lab”, provides mentoring, data from HMOs and hospitals and unparalleled access to leading global expertise from within Roche and aMoon.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. For more information, please visit www.roche.com
aMoon is a leading global HealthTech and Life Sciences venture capital fund headquartered in Israel. We partner with exceptional scientists and entrepreneurs to build great companies and accelerate cure for humanity’s most life-threatening conditions and global healthcare’s biggest cost drivers. We are passionate about giving the most promising thinkers and innovators the resources and support they need to propel their business and technology to the next level and beyond. With over $1.3 billion under management, we are looking to seize this unique moment in time that sees the convergence of health and technology in order accelerate the transformation of healthcare.
Contact us: [email protected]
